Market cap
$2,559 Mln
Revenue (TTM)
$250 Mln
P/E Ratio
44.4
P/B Ratio
6.5
Div. Yield
0.7 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
26.2
-
Debt to Equity
0.5
-
Book Value
$17.1
-
EPS
$2.5
-
Face value
--
-
Shares outstanding
22,847,798
10 Years Aggregate
CFO
$222.43 Mln
EBITDA
$240.18 Mln
Net Profit
$179.19 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
LeMaitre Vascular (LMAT)
| 35.5 | 0.7 | 26.3 | 33.9 | 17.6 | 16.6 | 21.3 |
|
BSE Sensex
| -8.1 | 5.0 | -6.9 | -3.5 | 8.4 | 9.7 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
LeMaitre Vascular (LMAT)
| -12.0 | 61.7 | 23.3 | -8.4 | 24.0 | 12.7 | 52.1 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
LeMaitre Vascular (LMAT)
|
109.9 | 2,559.0 | 249.6 | 57.7 | 32.2 | 15.8 | 44.4 | 6.5 |
| 8.4 | 5,496.2 | 6,552.2 | -551.4 | -6.1 | -9.9 | -- | 1.0 | |
| 261.3 | 6,916.8 | 2,589.9 | 168.8 | 21.4 | 2.5 | 42.9 | 1.2 | |
| 43.4 | 5,786.0 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.3 | |
| 134.4 | 7,836.3 | 551.4 | -189.3 | -15.6 | -26.3 | -- | 11.9 | |
| 88.7 | 5,587.1 | 1,541.6 | 233.6 | 21.6 | 21.4 | 25.2 | 5.2 | |
| 178.5 | 9,352.1 | 1,526.9 | -151.5 | 20.0 | -17.1 | 46.7 | 12.9 | |
| 325.5 | 12,737.9 | 1,403.7 | 177.7 | 14.7 | 13.8 | 71.5 | 8.9 | |
| 125.2 | 7,084.3 | 738.3 | 48.9 | 11.4 | 2.4 | 146.1 | 3.2 | |
| 30.3 | 13,363.9 | 6,178.4 | 626.5 | 13.0 | 11.9 | 21.9 | 2.5 |
Shareholding Pattern
View DetailsAbout LeMaitre Vascular (LMAT)
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are... cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Address: 63 Second Avenue, Burlington, MA, United States, 01803 Read more
-
Chairman & CEO
Mr. George W. LeMaitre
-
Chairman & CEO
Mr. George W. LeMaitre
-
Headquarters
Burlington, MA
-
Website
FAQs for LeMaitre Vascular (LMAT)
What is the current share price of LeMaitre Vascular Inc (LMAT) Today?
The share price of LeMaitre Vascular Inc (LMAT) is $109.91 (NASDAQ) as of 07-May-2026 10:33 EDT. LeMaitre Vascular Inc (LMAT) has given a return of 17.6% in the last 3 years.
What is the current PB & PE ratio of LeMaitre Vascular Inc (LMAT)?
The P/E ratio of LeMaitre Vascular Inc (LMAT) is 44.44 times as on 06-May-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
32.26
|
4.73
|
|
2024
|
47.92
|
6.26
|
|
2023
|
42.34
|
4.28
|
|
2022
|
49.59
|
3.82
|
|
2021
|
41.33
|
4.38
|
What is the 52 Week High and Low of LeMaitre Vascular Inc (LMAT)?
The 52-week high and low of LeMaitre Vascular Inc (LMAT) are Rs 118.01 and Rs 78.35 as of 07-May-2026.
What is the market cap of LeMaitre Vascular Inc (LMAT)?
LeMaitre Vascular Inc (LMAT) has a market capitalisation of $ 2,559 Mln as on 06-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in LeMaitre Vascular Inc (LMAT)?
Before investing in LeMaitre Vascular Inc (LMAT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.